Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Investing Activities (2020 - 2023)

Bio Essence (BIOE) has 4 years of Cash from Investing Activities data on record, last reported at -$87870.0 in Q4 2023.

  • For Q4 2023, Cash from Investing Activities fell 276.27% year-over-year to -$87870.0; the TTM value through Dec 2023 reached -$179919.0, down 78.02%, while the annual FY2024 figure was -$114.0, 99.88% up from the prior year.
  • Cash from Investing Activities reached -$87870.0 in Q4 2023 per BIOE's latest filing, down from $49851.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $49851.0 in Q4 2022 and bottomed at -$89847.0 in Q4 2021.
  • Average Cash from Investing Activities over 4 years is -$26577.0, with a median of -$10056.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: crashed 1463.1% in 2021, then skyrocketed 155.48% in 2022.
  • A 4-year view of Cash from Investing Activities shows it stood at -$5748.0 in 2020, then plummeted by 1463.1% to -$89847.0 in 2021, then surged by 155.48% to $49851.0 in 2022, then crashed by 276.27% to -$87870.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$87870.0 in Q4 2023, $49851.0 in Q4 2022, and -$52053.0 in Q3 2022.